Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MMAC-SF | Vemurafenib | Defactinib | 0.000 | 1.000 | uM | 72 | hr | 3 | 910 | 34 | 0.5397 | 0.6001 | 0.0374 | 0.0364 |
MMAC-SF | Vemurafenib | Saracatinib | 0.100 | 0.316 | uM | 72 | hr | 3 | 1212 | 34 | 0.9399 | 0.9306 | 0.0281 | 0.0304 |
MMAC-SF | Vemurafenib | PF562271 | 0.100 | 1.000 | uM | 72 | hr | 3 | 502 | 35 | 0.4728 | 0.5724 | 0.0697 | 0.0768 |
MMAC-SF | Vemurafenib | Saracatinib | 0.100 | 3.160 | uM | 72 | hr | 2 | 925 | 35 | 0.7101 | 0.6941 | 0.0378 | 0.0337 |
MMAC-SF | Vemurafenib | Saracatinib | 0.100 | 0.316 | uM | 72 | hr | 1 | 1049 | 35 | 0.8090 | 0.9306 | 0.0334 | 0.0304 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.000 | 1.000 | uM | 72 | hr | 2 | 737 | 35 | 0.6894 | 0.6789 | 0.0475 | 0.0471 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.100 | 1.000 | uM | 72 | hr | 3 | 563 | 36 | 0.5175 | 0.7182 | 0.0639 | 0.0494 |
MMAC-SF | Vemurafenib | Saracatinib | 0.316 | 1.000 | uM | 72 | hr | 3 | 635 | 36 | 0.4779 | 0.6590 | 0.0567 | 0.0562 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.100 | 3.160 | uM | 72 | hr | 2 | 757 | 37 | 0.7070 | 0.6959 | 0.0489 | 0.0496 |
MMAC-SF | Vemurafenib | PF562271 | 0.100 | 0.000 | uM | 72 | hr | 3 | 869 | 37 | 0.8424 | 0.8032 | 0.0426 | 0.0480 |
MZ7-mel | Vemurafenib | Saracatinib | 0.316 | 3.160 | uM | 72 | hr | 3 | 688 | 38 | 0.2120 | 0.3835 | 0.0552 | 0.0574 |
MMAC-SF | Vemurafenib | Saracatinib | 0.100 | 0.000 | uM | 72 | hr | 1 | 981 | 39 | 0.7516 | 0.7976 | 0.0398 | 0.0486 |
MMAC-SF | Vemurafenib | Saracatinib | 0.100 | 0.316 | uM | 72 | hr | 2 | 1347 | 40 | 1.0428 | 0.9306 | 0.0297 | 0.0304 |
MMAC-SF | Vemurafenib | Defactinib | 0.000 | 3.160 | uM | 72 | hr | 1 | 1027 | 40 | 0.6081 | 0.4909 | 0.0389 | 0.0363 |
MMAC-SF | Vemurafenib | PF562271 | 0.000 | 1.000 | uM | 72 | hr | 2 | 555 | 40 | 0.5214 | 0.6166 | 0.0721 | 0.0527 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.100 | 1.000 | uM | 72 | hr | 1 | 985 | 40 | 0.9280 | 0.7182 | 0.0406 | 0.0494 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.000 | 1.000 | uM | 72 | hr | 1 | 818 | 40 | 0.7640 | 0.6789 | 0.0489 | 0.0471 |
MMAC-SF | Vemurafenib | Dasatinib | 0.100 | 1.000 | uM | 72 | hr | 2 | 867 | 41 | 0.6326 | 0.6038 | 0.0473 | 0.0460 |
MMAC-SF | Vemurafenib | PF562271 | 0.100 | 0.000 | uM | 72 | hr | 2 | 894 | 41 | 0.8637 | 0.8032 | 0.0459 | 0.0480 |
MMAC-SF | Vemurafenib | Saracatinib | 0.100 | 1.000 | uM | 72 | hr | 2 | 984 | 41 | 0.7524 | 0.6896 | 0.0417 | 0.0319 |
MMAC-SF | Vemurafenib | PF562271 | 0.100 | 0.000 | uM | 72 | hr | 1 | 736 | 41 | 0.7037 | 0.8032 | 0.0557 | 0.0480 |
MMAC-SF | Vemurafenib | PF562271 | 0.000 | 1.000 | uM | 72 | hr | 1 | 811 | 41 | 0.7796 | 0.6166 | 0.0506 | 0.0527 |
MMAC-SF | Vemurafenib | Dasatinib | 0.100 | 1.000 | uM | 72 | hr | 1 | 959 | 43 | 0.7016 | 0.6038 | 0.0448 | 0.0460 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.000 | 3.160 | uM | 72 | hr | 1 | 1095 | 43 | 1.0331 | 0.7915 | 0.0393 | 0.0491 |
MMAC-SF | Vemurafenib | Saracatinib | 0.000 | 1.000 | uM | 72 | hr | 2 | 956 | 43 | 0.7285 | 0.8133 | 0.0450 | 0.0417 |